REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 439 filers reported holding REPLIGEN CORP in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $13,598,774 | -37.1% | 80,772 | -36.8% | 0.03% | -42.4% |
| Q4 2022 | $21,625,797 | +9426.8% | 127,729 | +10421.3% | 0.06% | +5800.0% |
| Q3 2022 | $227,000 | -55.5% | 1,214 | -36.9% | 0.00% | -50.0% |
| Q4 2021 | $510,000 | -95.5% | 1,925 | -96.6% | 0.00% | -96.2% |
| Q2 2021 | $11,216,000 | -61.8% | 56,185 | -62.8% | 0.05% | -63.4% |
| Q1 2021 | $29,357,000 | +40.2% | 151,008 | +38.2% | 0.14% | +25.0% |
| Q4 2020 | $20,939,000 | +12.4% | 109,268 | -13.4% | 0.12% | -15.3% |
| Q3 2020 | $18,624,000 | +80.4% | 126,232 | +51.2% | 0.14% | +52.2% |
| Q2 2020 | $10,321,000 | +198.2% | 83,496 | +132.9% | 0.09% | +119.5% |
| Q1 2020 | $3,461,000 | +166.4% | 35,850 | +137.3% | 0.04% | +412.5% |
| Q2 2019 | $1,299,000 | +173.5% | 15,109 | +87.9% | 0.01% | +166.7% |
| Q1 2019 | $475,000 | -51.8% | 8,043 | -56.9% | 0.00% | -57.1% |
| Q4 2018 | $985,000 | -63.7% | 18,677 | -67.6% | 0.01% | -41.7% |
| Q2 2018 | $2,711,000 | – | 57,622 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |